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Abstract
Purpose The best treatment for Achilles tendon (AT)
ruptures remains controversial. Long-term follow-up with
radiological and clinical measurements is needed.
Methods In this retrospective multicentre cohort study,
patients (n = 52) were assessed at a mean of 91 months fol-
low-up after unilateral AT rupture treated by open, percuta-
neous or conservative (non-surgical) treatment. Demographic
parameters, time off work, maximum calf circumference and
clinical scores (ATRS, Hannover, AOFAS) were evaluated.
Muscle volume and cross-sectional area of the calf and AT
length were measured on MR images and were compared
between groups and to each patient’s healthy contralateral leg.
Results Reduced muscle volume was found across all
groups with a higher muscle volume in the conservative
(729.9 ± 130.3 cm3) compared to the percutaneous group
(675.9 ± 207.4 cm3, p = 0.04). AT length was longer in
the affected leg (198.4 ± 24.1 vs. 180.6 ± 25.0 mm,
p \ 0.0001) without difference in subgroup analysis. Clini-
cally measured ankle dorsiflexion showed poor correlation
with AT length (R2 = 0.07, p = 0.008). Muscle volume
strongly correlated with the cross-sectional area (R2 = 0.6,
p \ 0.0001) but showed a weak correlation with the Hannover
score (R2 = 0.08, p = 0.048). Maximum calf circumference
correlated with muscle volume (R2 = 0.42, p \ 0.0001).
Conclusions No significant difference between the treat-
ment groups was found in muscle volume, AT length, clinical
measures or days off work. Cross-sectional area and maximum
calf circumference are cost-effective measurements and a good
approximation of muscle volume and can thus be used in a
clinical setting while clinical dorsiflexion should not be used.
Level of evidence III.
C. Rosso (&)  P. Vavken  C. Polzer  D. M. Buckland 
A. M. Mu¨ller  V. Valderrabano
Orthopaedic Department, University Hospital Basel
and University of Basel, Spitalstrasse 21,
4031 Basel, Switzerland
e-mail: Claudio.Rosso@unibas.ch
C. Polzer
e-mail: Caroline.Polzer@unibas.ch
A. M. Mu¨ller
e-mail: A.Mueller@usb.ch
V. Valderrabano
e-mail: Victor.Valderrabano@usb.ch
P. Vavken
Harvard School of Public Health, Boston, MA, USA
P. Vavken
Children’s Hospital Boston, Harvard Medical School,
Boston, MA, USA
e-mail: Patrick.vavken@childrens.harvard.edu
D. M. Buckland
Center for Advanced Orthopaedic Studies, Beth Israel Deaconess
Medical Center, Harvard Medical School, Boston, MA, USA
e-mail: Dan.Buckland@usb.ch; dbucklan@bidmc.harvard.edu
U. Studler
Department of Radiology, University Hospital Basel,
University of Basel, Basel, Switzerland
e-mail: Ueli.Studler@usb.ch
L. Weisskopf
Rennbahn Clinic, Muttenz, Switzerland
e-mail: weisskopf@rennbahnklinik.ch
M. Lottenbach
Cantons Hospital Fribourg, Fribourg, Switzerland
e-mail: lottenbachm@h-fr.ch
123
Knee Surg Sports Traumatol Arthrosc (2013) 21:1369–1377
DOI 10.1007/s00167-013-2407-1
Keywords Calf muscle volume  Cross-sectional area 
Achilles tendon length  Achilles tendon rupture
Introduction
Achilles tendon ruptures are common in sports medicine
and their incidence is increasing [1, 14]. Long-term
sequelae of Achilles tendon ruptures can be grave: the
injured athlete has to rest, and consequences such as
therapy, rehabilitation costs and absence from work pose a
substantial socio-economic cost. Thus, it is of pivotal
importance, both on the individual and societal level, to
identify those therapies with the best outcomes [28].
A common long-term problem in Achilles tendon rup-
ture reconstruction, with substantial influence on overall
outcome, has been muscle atrophy [13, 25]. A number of
studies emphasized the problem of muscle atrophy and its
functional implications on ligament and tendon repair, such
as poor outcomes and increased risk of re-tears [2, 22, 32,
35]. About the ankle joint, Valderrabano et al. [35] showed
muscle atrophy after reconstruction of posterior tibial ten-
don rupture. Gladstone et al. [4] and Liem et al. [15]
showed that muscle atrophy and fatty infiltration are not
reversed by successful tendon repair and play a significant
role in determining functional outcome. Thus, it is impor-
tant to assess muscle atrophy and fatty infiltration of the
triceps surae after Achilles tendon rupture treatments.
Experts agree that in active patients, surgical treatment of
acute Achilles tendon ruptures is superior to non-operative
treatment because it allowed an anatomical reconstruction
[1, 17, 20, 26, 29, 36]. However, to date, there is still lack of
long-term data concerning muscle atrophy––both in volume
and cross-sectional area––and fatty infiltration after different
types of Achilles tendon rupture treatment, and it is unclear
how such tissue degeneration would affect muscle force and
clinical outcomes.
It was therefore the primary objective of this study to
systematically assess muscle atrophy across the three
treatment groups (open repair, percutaneous repair or
conservative treatment) in a retrospective, assessor-blind,
multicentre study at a minimum follow-up of 3 years. The
second objective of this study was to test for an association
between Achilles tendon length, muscular degeneration
and clinical outcomes, including subgroup analyses by type
of treatment (open, percutaneous, conservative). It was
hypothesized that open surgery would perform best by
means of muscle atrophy and fatty infiltration across the
three treatment groups and that there was a significant
negative association between muscle atrophy and fatty
infiltration and clinical outcomes. It was also hypothesized
that conservative treatment yields excessive Achilles ten-
dons length after healing and that generally Achilles tendon
cannot be restored to their original length, independent of
treatment type.
Materials and methods
This study was designed as a retrospective, assessor-blinded,
multicentre cohort trial with consecutive patients. An IRB
approval was granted for this study by the local institutional
review board.
Fifty-two patients (females, 11 and males, 41) were
recruited from three orthopaedic centres. Demographic
data are shown in Fig. 1.
Patients post-unilateral Achilles tendon rupture were
contacted a minimum of 3 years after the injury. Further
inclusion criteria were: 20–65 years of age, a healthy
contralateral leg with physiological, clinically determined
alignment of the knee, foot and ankle, no trauma to the
healthy leg, no neuromuscular impairments including
muscle dystrophies, no other post-traumatic injuries or
osteoarthritis of the knee, foot or ankle of the affected leg.
Exclusion criteria were: re-rupture or re-operation of the
Achilles tendon, surgical site infection, neuromuscular
diseases including muscle dystrophies, ankle valgus of
more than 15 or ankle varus of more than 5, other known
pathologies of the non-affected leg, general MRI exclusion
criteria (e.g. pacemaker, other metal not qualifying for an
MRI, tattoos and claustrophobia) and a body mass index
(BMI) of [40 kg/m2. Conservatively treated patients were
all recruited from one of the study centres.
The post-treatment (operative or conservative) regimens
were identical in all study centres. Treatment was early
functional rehabilitation in a stability boot and a night
splint. After operative treatment or diagnosis (conserva-
tive), patients were allowed partial weight bearing for
2 weeks in 20 plantar flexion. For weeks 3 and 4, patients
were allowed full weight bearing with 20 of plantar
flexion and at week 5 and 6, patients were reduced to a 10
plantar flexing heel pad.
Demographic data and clinical assessment
The type of surgery was noted: open surgery, conservative
treatment and percutaneous surgery which consisted of
mini-open Kakiuchi [7] repairs, Ma and Griffith [16]
repairs and repairs using the Achillon device. The fol-
lowing clinical patient parameters were noted in a clinical
assessment of an orthopaedic surgeon (C.R.): gender, age,
body height, weight, BMI and activity level according to
the Valderrabano sports score (VSS) [35]. Additionally,
time off work, maximum calf circumference, thigh cir-
cumference 10 and 20 cm above the proximal patella
apex, ankle dorsiflexion, SF-36 quality of life, proportion
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of disabled pensions, Achilles tendon rupture score
(ATRS, max. 100 points) [23], Hannover score (max. 100
points) [33] and the AOFAS Hindfoot score (max. 100
points) [11], and adherence of the tendon to the skin were
evaluated.
Twenty-one patients were treated with open repair
(OPEN), 16 with percutaneous/mini-open repair (PRCT)
and 15 with conservative treatment (CONS). The mean
follow-up was 91.0 ± 31.3 (mean ± SD) months. Both
sides were ruptured equally often (n = 26 in both groups).
There was no significant difference in the average follow-
up duration between the different treatment groups. Mean
age at follow-up was 48.6 ± 8.7 years (range 23–55) with
49.9 ± 6.5 years in females and 48.2 ± 9.3 years in males
(n.s.) without any significant difference between the
groups. The mean body height was 176.8 ± 8.8 cm (range
157–196) with 166.5 ± 5.8 cm in females and
179.6 ± 7.2 cm in males (p \ 0.0001) but equally dis-
tributed among the treatment groups. The mean BMI was
26.2 ± 3.9 kg/m2 (range 19.7–39.4) with 25.7 ± 6.3 kg/m2
in females and 26.4 ± 3.0 kg/m2 in males (n.s.) and similar
in all treatment groups. The SF-36 scores were similar in all
groups (Fig. 2).
MRI assessment
MRI assessment was performed on both, the affected leg
and the healthy contralateral leg, which served as a normal,
matched control.
Imaging was carried out on a 3-TESLA scanner
(MAGNETOM Verio, Siemens Medical Solution,
Erlangen, Germany). Patients were examined in the supine
position with the ankle dorsiflexed at 90 (flexion neutral
position) and the knee in 0 flexion and fixed in that
position with straps and sandbags to assure reliable side
comparability. A peripheral angiography matrix coil with
16 coil elements was used for image acquisition. Three
sequences were acquired. First, a single-slab T1-weighted,
Fig. 1 Study design. This flow
chart depicts patient acquisition
at the three hospitals, the
number of exclusions as well as
the pathway of examinations
and analyses. USB University
Hospital Basel, KSLI Canton’s
Hospital Liestal, HFR Canton’s
Hospital Fribourg. All centres
are situated in Switzerland
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Fig. 2 SF-36 measures across treatment groups. The groups were not
significantly different from one another. The box ‘‘population
average’’ marks the line of the average score across the population.
Selected measures from SF-36, short form 36; no significant
differences in any measures were found
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magnetization-prepared, rapid acquisition gradient-echo
(MPRAGE) sequence (repetition time msec/echo time msec,
1,890/3.37; inversion time msec, 1,000; isotropic resolution,
1 9 1 9 1 mm) was obtained in the coronal plane. The
MPRAGE protocol was used to cover the entire lower leg
from above the femoral condyles (origin of gastrocnemius
muscles) through the bottom of the calcaneus allowing a 3D
reconstruction with slices of 1 mm. The accuracy of those
measurements was thus 0.1 cm. Second, axial T2-weighted
fat-saturated fast spin-echo images (5,000/76; echo train
length, 14; number of signals acquired, 1; section thickness,
3 mm; intersection gap, 0 mm; matrix size, 212 9 512 mm;
field of view, 168 9 400 mm) were acquired of both legs
simultaneously from the musculotendinous junction to the
calcaneal insertion of the Achilles tendon. Third, axial T1-
weighted fast spin-echo images (725/17; echo train length, 2;
number of signals acquired, 1; section thickness, 6 mm;
intersection gap, 4 mm; matrix size, 384 9 384; field of
view, 200 9 200 mm) were performed separately for both
legs resulting in approximately 65 slices per leg. Axial T1-
weighted imaging covered the area from above the origin site
of the gastrocnemius muscles (femoral condyles) to the
calcaneus.
Quantitative and qualitative radiological measurements
were noted. Muscle volume (MV) and cross-sectional
area (CSA) were measured in the T1-weighted spin-echo
images. Both parameters were measured on each calf
muscle separately (soleus muscle (SOL), gastrocnemius
medialis (GM) and lateralis (GL) muscles). The area of
every muscle was measured on each slice from the distal
appearance to the femoral condyles and multiplied by
1 cm (6 mm section thickness and 4 mm intersection
gap) resulting in a close approximation of the MV
(Fig. 3). Cross-sectional area was measured at a defined
point at the junction of the proximal third to the middle
third of the individually measured tibia length. The
length of the Achilles tendon was measured on recon-
structed isotropic images obtained by the MPRAGE
sequence. The proximal point was defined as the last
image before the appearance of the medial gastrocnemius
head. The first image showing the AT attached to the
calcaneus was defined as the distal point. This site is
rarely involved in Achilles tendon rupture and can thus
be measured in a ruptured, repaired or impaired tendon
[31]. The number of slices between the distal and the
proximal point was in turn the amount of millimetres the
Achilles tendon travelled between the two points (slices
of 1 mm). The resulting length is thus the length of the
Achilles tendon.
Semi-quantitative parameters were used to assess the
degree of tendon morphology and tendon sheath fluid. The
degree of tendon degeneration and tendon sheath fluid were
determined according to Valderrabano et al. on a four-point
grading scale (none/0, mild/?, moderate/??, severe/
???) on axial T2-weighted fat-saturated fast spin-echo
images [34]. Fatty atrophy was defined as originally pub-
lished on CT images and adapted to MR images for rotator
cuff muscle integrity [3, 5]. Radiological parameters were
measured using the Santesoft DICOM Editor, Version
3.1.11, Athens, Greece.
Statistical analysis
The sample size was based on the precision of the volume
measurements. Based on estimates of MV in three different
treatment groups from the literature, an alpha of 5 %, a
power of 80 % and a minimum sample size of n = 43
patients were required. Thus, after including 20 % (n = 9)
to account for potential patient attrition or data loss, we
included n = 43 ? 9, or n = 52, healthy patients in this
study. We used descriptive statistics including mean with
standard deviation and frequencies to describe the popula-
tions, as appropriate. A one-way analysis of variance
(ANOVA) with Bonferroni post hoc analysis was used to
compare the parameters noted in Tables 1 and 2 except of
skin palpation at the Achilles tendon, where a Chi-square
test was used. For all comparisons, R2 values were calcu-
lated in addition to the ANOVA p values. For comparison of
the affected with the healthy side, a paired t test was used.
All reported tests were performed at the two-sided 5 %
significance level. All analyses were performed with IBM
SPSS Statistics Version 20.0, IBM Corporation, Armonk,
NY, USA.
Fig. 3 Muscle volume measurement. The muscular areas of the
gastrocnemius and soleus muscle were measured on each axial T1-
weighted fast spin-echo image. The area was multiplied by the sum of
the slice thickness and the intersection gap in order to obtain the total
muscle volume. SOL, soleus muscle; GM, gastrocnemius medialis
muscle; GL, gastrocnemius lateralis muscle; TIB, tibia; FIB, fibula
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Results
Clinical assessment
For all treatment groups, days off work were not signifi-
cantly different; even though it was striking that conser-
vatively treated patients missed twice as many days of
work as patients treated with open surgery (Table 1). When
comparing surgically treated patients (open and percuta-
neous) with conservatively treated patients, no difference
could be found (surgical, 48.3 ± 47.9 days (range 3–252);
conservative, 75.4 ± 177.9 days (range 0–700), n.s.).
Additionally, no disability pensions were paid out in any of
the treatment groups.
In general, the clinical scores were good to excellent
with only few outliers across the subgroups. The clinical
scores showed good to excellent results without statistical
significant difference (Table 1). Muscle volume correlated
only to a small degree with the Hannover score but not with
the ATRS or AOFAS hindfoot score (Table 3) as did fatty
atrophy (Hannover, R2 = 0.03, n.s.; ATRS, R2 = 0.04,
n.s.; AOFAS, R2 = 0.10, p = 0.02, respectively) showing
little predictability of MV and fatty atrophy by clinical
scores.
Maximum calf circumference (MCC) showed a signifi-
cant difference between the affected and healthy leg
(Table 1). Also, MCC was a good predictor of the degree
of MV loss when the ratio of affected/healthy was evalu-
ated (R2 = 0.37, p \ 0.0001). This was also true when
looking at the absolute measures on the affected side and
the healthy side (Table 3). The following algorithm gave a
good estimate of the MV loss:
Muscle volume (cm3Þ ¼ 35
 maximum calf circumference (cm) - 566
(R2 = 0.42, p \ 0.0001).
Adherent scars were seen to a higher degree (56 %) in
patients treated percutaneously compared to 33 % in the
open surgery group (p = 0.01). No patient had irritations
of the sural nerve.
In a subgroup analysis on gender differences, clinical
values did not significantly differ (not depicted).
Table 1 Patient demographics and clinical outcomes
Treatment group
Open
(n = 21)
Percutaneous
(n = 16)
Conservative
(n = 15)
Total
(n = 52)
ANOVA
p value
t test vs.
healthy
p valueMean (SD) Mean (SD) Mean (SD) Mean (SD)
Follow-up (months) 97.5 (30.8) 83.4 (34.2) 90.1 (29) 91 (31.30) n.s. n.a.
Age at follow-up (years) 48.2 (10.6) 46.4 (7.1) 51.3 (6.9) 48.6 (8.7) n.s. n.a.
Age at injury (years) 40.3 (10.1) 39.6 (7.7) 44.2 (7.4) 41.2 (8.7) n.s. n.a.
Days off work 38 (23) 62 (67) 75 (175) 56 (100) n.s. n.a.
Height (cm) 176.4 (9.2) 175.3 (8) 178.9 (9) 176.8 (8.8) n.s. n.a.
Weight (kg) 82.1 (13.7) 78.1 (13.8) 86.2 (9.8) 82.1 (12.9) n.s. n.a.
BMI (kg/m2) 26.4 (4) 25.3 (3.2) 27.1 (4.3) 26.2 (3.9) n.s. n.a.
AOFAS score 97 (5.9) 93.2 (7.7) 93.4 (8.3) 94.8 (7.3) n.s. n.a.
ATRS score 90.5 (20.1) 88.4 (10.7) 90.6 (12.7) 89.9 (15.4) n.s. n.a.
Hannover score 86.7 (6.8) 80.2 (12.2) 79.1 (11.9) 82.5 (10.6) n.s. n.a.
Max.calf circumf. affected (cm) 38.1 (3.4) 37.7 (3.1) 37.7 (3.7) 37.9 (3.3) n.s. <0.0001
Max.calf circumf. healthy (cm) 39.6 (3.1) 39.1 (2.6) 38.8 (3.4) 39.2 (3) n.s. n.a.
Max.calf circumf. % 0.96 (0.04) 0.96 (0.03) 0.97 (0.03) 0.97 (0.03) n.s. n.a.
Thigh 20 cm above pat. affected
(cm)
52.1 (5.5) 51.1 (4.6) 52.2 (5.2) 51.8 (5.1) n.s. n.s.
Thigh 20 cm above pat. healthy
(cm)
52.6 (4.7) 51.3 (4.7) 52.7 (4.8) 52.2 (4.7) n.s. n.a.
Thigh 20 cm % 0.99 (0.04) 1 (0.01) 0.99 (0.03) 0.99 (0.03) n.s. n.a.
SF36 physical funct. functioning 96.2 (6.5) 94.1 (7.1) 91.7 (14.2) 94.2 (9.5) n.s. n.a.
SF36 role physical 22.6 (6.7) 25 (0) 22.9 (5.7) 23.4 (5.3) n.s. n.a.
SF36 bodily pain 10.5 (19.9) 4.4 (6.3) 13.3 (25.5) 9.4 (18.9) n.s. n.a.
% Percent of healthy side, SF36 short form 36, circumf circumference, ATRS Achilles tendon rupture score, AOFAS AOFAS hindfoot score, pat
patella, * Chi square, n.a. not applicable, n.s not significant
Knee Surg Sports Traumatol Arthrosc (2013) 21:1369–1377 1373
123
MRI assessment
Significant MV loss of the affected leg compared to the
matched, healthy leg was found across the three treatment
subgroups (mean, 17 % reduction). There was a 9.1 %
higher MV in the conservatively treated group as compared
to the percutaneous treated group (Table 1). When com-
paring the operative groups (open and percutaneous toge-
ther) with the conservative group, no difference could be
found (n.s.). The subgroup analysis for the different mus-
cles (SOL, GM, GL) did not show any significant differ-
ences. When looking at muscle atrophy as defined by fatty
infiltration, the soleus and the gastrocnemius were signifi-
cantly affected (p \ 0.0001 and 0.006, respectively).
Analysis of the CSA revealed no significant difference in
the treatment subgroups as well as the muscle subgroups
(SOL, GM, GL).
The mean Achilles tendon was significantly longer in
the affected leg when compared to the healthy leg
(198.4 ± 24.1 vs. 180.6 ± 25.0 mm, p \ 0.0001) but not
significantly different between treatment groups. In addi-
tion, there was no association between the type of treat-
ment and MV (n.s.), CSA (n.s.), and degree fatty
infiltration (n.s.).
Total MV of the healthy or affected side, respectively,
did not correlate with the Achilles tendon length on the
respective side. Clinically measured ankle dorsiflexion
showed only a poor correlation with Achilles tendon length
(R2 = 0.07, p = 0.008), for this measurement, all legs and
Achilles tendon lengths were evaluated (n = 104). The
Table 2 MRI assessment
Treatment group
Open (n = 21) Percutaneous (n = 16) Conservative (n = 15) Total (n = 52) ANOVA
p value
t test vs. healthy
p valueMean (SD) Mean (SD) Mean (SD) Mean (SD)
Muscle volume
Total affected (cm3) 701.1 (141.2) 675.9 (207.4) 729.9 (130.3) 701.6 (159.9) n.s. <0.0001
Total healthy (cm3) 853.7 (164.8) 863 (183.8) 833.6 (121.4) 850.8 (157.4) n.s. n.a.
Total % 0.82 (0.07) 0.79 (0.17) 0.88 (0.11) 0.83 (0.12) n.s. n.a.
Cross-sectional area
Total affected (cm2) 42.4 (8.7) 40.5 (9.8) 43.9 (7.1) 42.3 (8.6) n.s. <0.0001
Total healthy (cm2) 46.8 (12) 44.8 (11.8) 45.8 (6.5) 45.9 (10.5) n.s. n.a.
Total % 0.94 (0.22) 0.94 (0.25) 0.96 (0.08) 0.94 (0.2) n.s. n.a.
Tendon
Morphology affected sheath 0.38 (0.59) 0.5 (0.63) 0.43 (0.51) 0.43 (0.57) n.s. n.s.
Sheath fluid affected 0.19 (0.51) 0.13 (0.34) 0.2 (0.41) 0.17 (0.43) n.s. n.s.
Achilles tendon length
Affected (mm) 195.6 (27) 199.6 (20) 201.1 (25) 198.4 (24) n.s. <0.0001
Healthy (mm) 177.4 (28) 179.4 (23) 186.3 (24) 180.6 (25) n.s. n.a.
% 1.11 (0.09) 1.12 (0.08) 1.08 (0.08) 1.1 (0.08) n.s. n.a.
%, Percent of healthy side; n.a., not applicable
Table 3 Predictors of muscle volume (R square)
Muscle volume
Affected side (n = 52) Health side (n = 52) Total (n = 104) Ratio (affected/healthy)
Cross-sectional area 0.79a 0.49a 0.60a 0.0003
Maximum calf circumference 0.41a 0.38a 0.42a 0.37a
Hannover 0.08a
ATRS 0.049a
AOFAS 0.001a
Depicted are R2 values
Hannover, Hannover Achilles tendon score; ATRS, Achilles tendon rupture score; AOFAS, American Orthopaedic Foot and Ankle Society
Hindfoot score; total, n = 104
a Significant
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same weak correlation was found for the affected
(R2 = 0.14, p = 0.006) and the healthy side (R2 = 0.01,
n.s.) separately. Clinically measured passive dorsiflexion
measurements did not show a difference between the
treatment groups (open, 19.7 ± 3.2; percutaneous,
19.9 ± 3.6; conservative, 19.8 ± 6.7; n.s.). In addi-
tion, the affected (19.8 ± 4.5) and the healthy side
(18.4 ± 5.7) did not show a significant difference (n.s.).
As expected, MV correlated with CSA (Table 3).
Discussion
This study focused on functional and imaging outcomes
after Achilles tendon treatment with comparison of the
three treatment mainstreams (open repair, percutaneous
suture and non-operative treatment). No significant differ-
ences in MRI and clinical scores outcomes were found
between the three treatment groups.
Controversy remains as to which treatment algorithm is
best followed for acute Achilles tendon rupture. However,
there is consensus that open reconstruction is best suitable
for athletes [1]. Whichever treatment is chosen, sequelae
from surgical site infections, scar adhesions and sural nerve
irritation in operative techniques [37], higher re-rupture
rates in conservative treatment [10] and deep vein throm-
bosis, muscle atrophy [6, 13, 25], days off work and loss of
function for all treatments exist [25].
Muscle atrophy as a potential consequence of Achilles
tendon ruptures has not been correlated with Achilles
tendon length. These measurements were now performed
on treated and healthy tendons and we found them to be
healed in over length with a mean of 110 % compared to
the healthy side showing that original tendon length cannot
be restored independent of the type of treatment. Until
now, Achilles tendon length was measured by implanting
metal markers into the tendon and looking at the gapping or
increase in ankle dorsiflexion in different post-operative
rehabilitation protocols without measuring the actual
Achilles tendon length, thus lacking direct comparison to
our findings [8, 21, 22]. In a previous study, we evaluated
Achilles tendon length [27] and showed that dorsiflexion of
the ankle joint, although significant, is only a weak pre-
dictor (R2 = 0.07) of Achilles tendon length and should
thus not be used to assess Achilles tendon overlength after
repairs [12, 21].
Muscle volume was found to be diminished in all
treatment groups. Although open surgery is intended to
result in better anatomic reconstruction, we found a MV
loss of 18 % in the open surgery group. To our knowledge,
MV of the posterior calf has never been measured in an
accurate manner. When looking at fatty infiltration as an
indicator of muscle atrophy, there was no significant
difference between the treatment groups either. Neverthe-
less, fatty atrophy was still present after more than
7.5 years of follow-up. With the supraspinatus muscle, it is
already known that muscle atrophy does not completely
reverse [15]. We can support this finding by looking at the
posterior calf muscles. A recent study of Olsson et al. [24]
revealed that major functional deficits persist even 2 years
after Achilles tendon rupture and that patients do not
improve significantly between 1 and 2 years after the
rupture. Rebeccato et al. retrospectively compared 52
tendon ruptures with a minimal follow-up of 12 months.
The results revealed a loss of posterior muscle compart-
ment area of 18 % in the open group, 19 % with
Ma-Griffith and 9 % in Kakiuchi repair group, respec-
tively. While Haggmark et al. [6] compared 15 non-oper-
atively with 8 surgically treated patients and showed a
significant reduction in calf muscle area (no follow-up
stated), Leppilahti et al. [13] showed calf muscle atrophy of
15 % on the affected leg in the analysis of CSA by means
of CT scans (mean 3.1 years follow-up). In our findings,
the CSA was higher after more than 7.5 years of follow-up
although not significantly different. This might be due to
the fact that patients might recover to a high degree even
between 2.9 years (Rebeccato et al.) and 7.5 years (our
cohort) of follow-up. The affected muscles and tendons
might recover after such a long follow-up. Another fact
that supports the recovery theory is the circumstance that
we saw a reduction in MCC of -1.3 cm which was noted
to be -2.55 cm in the study of Rebeccato et al. [25].
Although days off work did not significantly differ
throughout the treatment groups, it was notable that there
were almost twice as many days missed in conservative
treatment compared to open surgery, though this might be
due to the large standard deviation in the conservatively
treated group. This should be considered when cost effec-
tiveness of treatments is discussed. While conservative
treatment might be cheaper in direct treatment costs, total
societal cost might be equivalent if patients return to work
consistently earlier after open treatment. Percutaneous
treatment was situated in between the two. When compared
to other studies, days off work have been reported to be in
the same range [18, 25].
All clinical scores showed good to excellent results.
These results were consistent with the literature stating the
same ranges even after shorter follow-up periods [9, 30].
Although clinical scores might be a good measure for
short- to mid-term outcome, it appeared that the discrimi-
nation of results in a long-term follow-up become more
difficult in the very good to excellent range. The fact of less
muscle atrophy in our long-term follow-up did not add to a
better outcome by means of clinical scores.
Of great clinical interest might be two parameters: CSA
and MCC both showing strong correlations with MV
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(Table 3). The strong correlation between MV and CSA
will make it easy to approximate MV by simple measure-
ments on ultrasonography and replace the costly and time-
consuming MRI measurements. This supports other stud-
ies, which have used the CSA for the approximation of calf
MV [6, 13, 19, 25]. Even less costly is the clinical mea-
surement of maximum calf circumference. In contrast to
Haggmark et al., who showed a poor correlation, we found
a strong correlation of cross-sectional area with muscle
volume. This could be due to the fact that Haggmark only
measured the CSA and not the MV of the whole posterior
calf, giving less accurate results. When looking at corre-
lations between CSA and maximum calf circumference, the
latter seemed to be a good predictor of CSA on the affected
side as well as for the healthy side.
Strengths of this study were the strict in- and exclusion
criteria as well as the long follow-up time of 91 months.
Radiologists and radiology assistants were blinded for the
study. Additionally, the orthopaedic surgeon performing
the follow-up measurements was independent and did not
treat the patients before or after the study. For the first time
in the literature, MV was measured for the triceps surae
and correlated to cross-sectional area, Achilles tendon
length and clinical parameters. Fatty atrophy grading
according to Goutallier was introduced into calf muscles
[5].
There were certain limitations to this study. Firstly, there
might be a selection bias and patients that did not have a
good outcome might not consent to be followed up. We
tried to overcome this burden by contacting all consecutive
patients from the database in the years stated in Fig. 1.
Operative indications and treatment across centres in a
multicentre setup might differ considerably making the
operative groups heterogeneous. Additionally, some
patients were lost due to the time-consuming examinations
at different sites.
Conclusions
No significant difference between the treatment groups was
found by means of clinical scores, days off work, clinical
measurements, ATL, MV after more than 7.5 years of
follow-up. No general recommendation can be given on the
generally best treatment option even after examining con-
secutive patients. Ultrasonography and MCC are easy and
cost-effective measurements and a very good approxima-
tion of MV of the posterior calf even in the untreated limb
and can thus be used in daily clinical work.
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